MiniMed Group, Inc.
18.34USD
+0.0500 (+0.27%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MMED.
| In $M except per-share | Q1 FY27 | Q4 FY26* | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 843 | 837 | 790 | — | 723 | 724 | 687 | — |
| Cost of Revenue | 378 | 357 | 428 | — | 314 | 318 | 292 | — |
| Gross Profit | 465 | 480 | 362 | — | 409 | 405 | 395 | — |
| Operating Income | 5 | -93 | -100 | — | -13 | -148 | 21 | — |
| Net Income | 0 | -185 | -119 | -5 | -19 | -172 | -10 | -5 |
| EPS (Diluted) | $0.00 | -$0.71 | -$0.47 | — | -$0.08 | -$0.68 | -$0.04 | — |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)